Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
about
Targeted Therapies in Adult B-Cell MalignanciesAdoptive T-cell therapy for cancer: The era of engineered T cellsA Positive Role of Cytokine-Induced Killer Cell Therapy on Gastric Cancer Therapy in a Chinese Population: A Systematic Meta-Analysis.Prognostic and predictive biomarkers in melanoma: an update.Cellular immunotherapy of cancer: an overview and future directions.Generation of CD8(+) T cells expressing two additional T-cell receptors (TETARs) for personalised melanoma therapy.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Contemporary management of patients with penile cancer and lymph node metastasis.Raising the bar: optimizing combinations of targeted therapy and immunotherapy.Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer.Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.Expansion and Antitumor Cytotoxicity of T-Cells Are Augmented by Substrate-Bound CCL21 and Intercellular Adhesion Molecule 1.Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
P2860
Q26783195-54070E5F-8F45-4BAA-B2DE-206F1CFB01BAQ26800611-1E9A9001-1352-4855-B764-B5C04EADED57Q36263711-2D19208C-F000-4C30-921D-C1B4BDFD789CQ38653619-79E49E34-FC33-4C04-821F-FF355F86C518Q38673161-C053EC23-D7F8-4A12-8D6F-6DBEBFD613E3Q38852674-1761702F-0A90-48F6-88C2-943BD354B000Q38873974-DF6478CD-FABD-4D41-A760-A5052F6A8E84Q39237306-AF5CA969-0F6B-45D8-B63E-A2952B12495DQ41980361-09701460-D392-4B61-880F-0F1F2987E571Q47157659-EE586E85-A01B-446C-98E4-2BAE574EF7E0Q47157821-569B1AE6-D61D-474C-AF5E-43243B5726D7Q54977188-F60CCC72-F634-48F9-AEFD-CFA471BF90AFQ55446962-D9A8E855-BAE7-43A4-9CF0-AA8B66747D57Q58737536-8DBE4E9D-C14F-4B10-8F9B-0F54C1408AEF
P2860
Achievements and challenges of adoptive T cell therapy with tumor-infiltrating or blood-derived lymphocytes for metastatic melanoma: what is needed to achieve standard of care?
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Achievements and challenges of ...... d to achieve standard of care?
@en
type
label
Achievements and challenges of ...... d to achieve standard of care?
@en
prefLabel
Achievements and challenges of ...... d to achieve standard of care?
@en
P2860
P1476
Achievements and challenges of ...... d to achieve standard of care?
@en
P2093
Els M Verdegaal
P2860
P2888
P304
P356
10.1007/S00262-014-1580-5
P577
2014-08-07T00:00:00Z
P6179
1000555480